-
Jun 20, 2023, 10:57
by
Amerigo Scientific launches its ultra-low temperature freezers with a temperature range from -40°C to -86°C.
Full story
-
Jun 20, 2023, 10:57
by
CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023
CluePoints and partners present and discuss the results of a new study examining RBQM use and adoption.
Full story
-
Jun 20, 2023, 10:57
by
Full story
-
Jun 20, 2023, 10:57
by
Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.
Full story
-
Jun 16, 2023, 11:09
by
Full story
-
Jun 16, 2023, 11:09
by
Full story
-
Jun 16, 2023, 10:08
by
Full story
-
Jun 16, 2023, 10:08
by
Full story
-
Jun 16, 2023, 10:08
by
Full story
-
Jun 16, 2023, 09:58
by
Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.
Full story
-
Jun 16, 2023, 01:00
by
User Not Found
Clinical Research News | Global clinical trial programs are complex, often encompassing dozens of studies for increasingly uncommon indications. Sponsors of these programs are wisely seeking out independent adjudication of clinical events, or endpoints, that occur over the course of the trial to ensure patient safety and the efficacy of drugs and devices. While endpoint adjudication is not required by regulatory bodies, it can deliver valuable insights during a trial and lend strong, unbiased support for approvals down the road.
Full story
-
Jun 15, 2023, 09:48
by
PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.
Full story
-
Jun 15, 2023, 09:48
by
BullFrog AI Holdings, Inc. announced the expansion of its worldwide license agreement with the Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for use of patented technology powering the Company’s bfLEAP™ platform, an AI-driven platform for analyzing drug development data to potentially make life-saving therapies and treatments available to patients more quickly.
Full story
-
Jun 15, 2023, 09:48
by
MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
Full story
-
Jun 15, 2023, 09:48
by
AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.
Full story
-
Jun 15, 2023, 09:48
by
This article highlights how AI and automation are driving innovation in clinical trial research by improving patient outcomes, reducing costs, and overcoming traditional barriers to progress.
Full story
-
Jun 14, 2023, 10:33
by
SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.
Full story
-
Jun 14, 2023, 10:33
by
Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.
Full story
-
Jun 14, 2023, 01:00
by
User Not Found
Clinical Research News | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.
Full story
-
Jun 13, 2023, 13:02
by
Inizio Medical has announced a top-level hire in its senior leadership team, with the appointment of Shauna Aherne as President of Medical Excellence, Specialized Services.
Full story